Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

April 9, 2018

Study Completion Date

May 18, 2018

Conditions
Diabetic Macular EdemaDiabetic RetinopathyClinically Significant Macular Edema
Interventions
DRUG

Aflibercept Injection [Eylea]

Intravitreal Aflibercept injections were performed by vitreoretinal consultant at the place of study.

Trial Locations (1)

10430

Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia, RSCM Kirana, Jakarta Pusat

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Indonesia University

OTHER